How Neutropenia Medications Work

Neutropenia is a condition characterized by an abnormally low count of neutrophils, a type of white blood cell that plays a crucial role in fighting infections. Medications used to treat neutropenia work by stimulating the production and release of neutrophils from the bone marrow.

Gold Standard: G-CSF (Granulocyte-Colony Stimulating Factor) Therapy

The gold standard for treating neutropenia is G-CSF therapy, which involves administering a recombinant form of human G-CSF. This medication stimulates the bone marrow to produce more neutrophils and release them into the bloodstream. G-CSF therapy has been shown to be effective in increasing neutrophil counts and reducing the risk of infections.

Alternatives to G-CSF Therapy

• Filgrastim (Neupogen): A recombinant form of human G-CSF, similar to G-CSF therapy but with a slightly different mechanism of action.
• Sargramostim (Leukine): A recombinant form of human GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor), which stimulates the production and release of neutrophils and macrophages.
• Corticosteroids: While not a primary treatment for neutropenia, corticosteroids may be used in certain cases to reduce inflammation and increase neutrophil counts.